Effect of polymer molecular weight on nanocomminution of poorly soluble drug

Drug Delivery

Volumn 15, Issue 5, 2008, Pages 347-353

  Choi, Ji Yeun ^a   Park, Chul Ho ^a   Lee, Jonghwi ^a  

^a Chung Ang University   (South Korea)

Author keywords

Milling; Molecular weight; Nanoparticles; Nanosuspension; Particle size

Indexed keywords

DRUG; HYDROXYPROPYLCELLULOSE; ITRACONAZOLE; NANOPARTICLE; POLYMER; STABILIZING AGENT;

ADSORPTION; ARTICLE; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STRUCTURE; KINETICS; MOLECULAR WEIGHT; NANOCOMMINUTION; PARTICLE SIZE; PRIORITY JOURNAL; REDUCTION; SOLID; STEREOSPECIFICITY; TOOL USE;

CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EXCIPIENTS; ITRACONAZOLE; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR WEIGHT; NANOPARTICLES; PARTICLE SIZE; POLYMERS; POWDERS; SOLUBILITY; SURFACE-ACTIVE AGENTS; SUSPENSIONS; WATER;

EID: 50849113139     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540802039113     Document Type: Article

References (29)

1. Adamson, A.W., and Gast, A.P. 1997. Physical Chemistry of Surfaces, 348, 506. New York: John Wiley & Sons.
2. Amidon, G.L., Leenernäs, H., Shah, V.P., and Crison, J.R. 1995. Theoretical basis for a biopharmaceutical drug classification: the correlation of in vivo drug product dissolution and in vivo bioavailability. Pharm. Res. 12 (3):413-420.
3. Berglund, K.D., Przybycien, T.M., and Tilton, R.D. 2003a. Coadsorption of sodium dodecyl sulfate with hydrophobically modified nonionic cellulose polymers. 1. Role of polymer hydrophobic modification. Langmuir 19:2705-2713.
4. Berglund, K.D., Przybycien, T.M., and Tilton, R.D. 2003b. Coadsorption of sodium dodecyl sulfate with hydrophobically modified nonionic cellulose polymers. 2. Role of surface selectivity in adsorption hysteresis. Langmuir 19:2714-2721.
5. Choi, J.-Y., Yoo, J.Y., Kwak, H.-S., Nam, B.U., and Lee, J. 2005. Role of polymeric stabilizers for drug nanocrystal dispersions. Curr. Appl. Physics 5:472-474.
6. Craig, D.Q.M. 2002. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 231:131-144.
7. Evertsson, H., and Nilsson, S. 1997. Microviscosity in clusters of ethyl hydroxyethyl cellulose and sodium dodecyl sulfate formed in dilute aqueous solutions as determined with fluorescence probe techniques. Macromolecules 30:2377-2385.
8. Grau, M.J., Kayser, O., and Müller, R.H. 2000. Nanosuspensions of poorly soluble drugs - reproducibility of small scale production. Int. J. Pharm. 196:155-157.
9. Hill, T.L. 2001. A different approach to nanothermodynamics. Nano Lett. 1:273-275.
10. Kumar, C.S.S.R. (ed.) 2006. Preparation methods of drug nanoparticles. In Biological and Pharmaceutical Nanomaterials (Nanotechnologies for the Lifesciences, vol. 2). Weinheim: Wiley Science, 225.
11. Lee, J. 2003. Drug nano- and microparticles processed into solid dosage forms: physical properties. J. Pharm. Sci. 92 (10):2057-2068.
12. Lee, J. 2004. Intrinsic adhesion forces of lubricants to steel surface. J. Pharm. Sci. 93(9):2310-2318.
13. Lee, J., Lee, S.-J., Choi, J.-Y., Yoo, J.Y., and Ahn, C.-H. 2005. Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion. Eur. J. Pharm. Sci. 24:441-449.
14. Leuner, C., and Dressman, J. 2000. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50:47-60.
15. Liu, R. (ed). 2000. Particle size reduction, in water-insoluble drug formation. IL: Buffalo Grove, Interpharm Press, 455-492.
16. Liversidge, G.G., and Conzentino, P. 1995. Drug particle size reduction for decreasing gastic irritancy and enhancing absorption of naproxen in rats. Int. J. Pharm. 125:309-313.
17. Liversidge, G.G., and Cundy, K. 1995. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int. J. Pharm. 125:91-97.
18. Merisko-Liversidge, E., Sarpotdar, P., Bruno, J., Hajj, S., Wei, L., Peltier, N., Rake, J., Shaw, J.M., Pugh, S., Pollin, L., Jones, J., Corbett, T., Cooper, E., and Liversidge, G.G. 1996. Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs. Pharm. Res. 13:272-278.
19. Morrison, I.D., and Ross, S. 2002. Colloidal Dispersions, New York: Wiley-Interscience, 225.
20. Ploehn, H.J., and Russel, W.B. 1990. Interactions between colloidal particles and soluble polymers. Adv. Chemi Eng 15:137-228.
21. Rasenack, N., and Muller, B.W. 2002. Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs. Pharm. Res. 19(12):1894-1900.
22. Rowe, R.C., Sheskey, P.J., and Weller, P.J. 2003. Handbook of Pharmaceutical Excipients, 4th ed. Pharmaceutical Press.
23. Serajuddin, A.T.M. 1999. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 88 (10):1058-1066.
24. Siddiquee, S.K., and Egmond, J.W. 2002. Molecular weight dependence of shear-induced structures in nematic semiflexible polymer solutions. J. Rheol. 46 (2):367-381.
25. Six, K., Verreck, G., Peeters, J., Brewster, M., and van den Mooter, G. 2004. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers. J. Pharm. Sci. 93 (1):124-131.
26. Takano, R., Sugano, K., Higashida, A., Hayashi, Y., Machida, M., Aso, Y., and Yamashita, S. 2006. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test. Pharm. Res. 23 (6):1144-1156.
27. Torchilin, V. 2000. Drug targeting. Eur. J. Pharm. Sci. 11(suppl 2):S81.
28. Yamada, T., Saito, N., and Imai, T. 1999. Effect of grinding with hydroxypropyl cellulose on the dissolution and particle size of a poorly water-soluble drug. Chem. Pharm. Bull. 47 (9):1311-1313.
29. Zheng, J.Y., and Bosch, H.W. 1997. Sterile filtration of nanocrystal drug formulation. Drug Devel Ind Pharm 23(11):1087-1093.